GaitQ is a spinout from the University of Oxford that has its roots in the Department of Physiology, Anatomy and Genetics (DPAG) and the Institute of Biomedical Engineering (IBME). The focus of GaitQ’s first product, GaitThaw, is on improving the lives of people living with Parkinson’s.

Our team has been working almost exclusively with Parkinson’s Disease for the last 3 years. We have contacted people related to the disease (PwP, families/carers, neuro-consultants, PD nurses and physiotherapists) across 3 continents, using their input to create and developed our technology. Recently, we have finished a successful clinical investigation to test our prototype with support from the Wellcome Trust and Oxford University Hospital Foundation Trust.

The GaitThaw technology has completed a successful clinical evaluation and, subject to securing funding, will be launched in 2021.